Novo Nordisk and Valo expand cardiometabolic drug partnership
Novo Nordisk has expanded its partnership with Valo Health to advance new therapies for type 2 diabetes, obesity and cardiometabolic…
All articles by Archana Rani
Archana Rani
-
-
CTI announces partnership for oncology drug development
CTI Clinical Trial & Consulting Services (CTI) and Crown Bioscience have announced a strategic partnership aimed at bolstering consulting services…
-
Touchlight to supply GMP dbDNA for UK Zika vaccine study
Contract development and manufacturing organisation Touchlight has collaborated with the UK's University of Nottingham to supply good manufacturing practice (GMP)…
-
Innovent’s Dupert approved in China to treat lung cancer
China's National Medical Products Administration (NMPA) has granted approval for Innovent Biologics’ Kristen rat sarcoma (KRAS) G12C inhibitor, Dupert (fulzerasib),…
-
FDA accepts BMS’ sBLA for Opdivo-Yervoy combo for HCC
The US Food and Drug Administration (FDA) has accepted the supplemental biologics licence application (sBLA) filed by Bristol Myers Squibb…
-
Accenture invests in Earli to advance early cancer detection tech
Accenture has invested in biotechnology company Earli to advance early cancer detection technologies. Facilitated through Accenture Ventures, the investment aims…
-
Liquidia’s YUTREPIA inhalation powder gains tentative FDA approval
Biopharmaceutical company Liquidia has received tentative approval from the US Food and Drug Administration (FDA) for YUTREPIA (treprostinil) inhalation powder…
-
NMPA approves Astellas’ PADCEV for advanced urothelial cancer
The Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has approved Astellas’ PADCEV (enfortumab vedotin), a…
-
EC approves AbbVie’s TEPKINLY for follicular lymphoma
The European Commission (EC) has granted conditional marketing authorisation for AbbVie’s TEPKINLY (epcoritamab), an IgG1-bispecific antibody, for the treatment of…
-
Gilead Sciences reports net income rise in Q2 2024
Gilead Sciences has reported net income attributable to the company at $1.61bn, up from $1.04bn in the corresponding quarter of…